Rapid production of interleukin-2-secreting tumor cells by herpes simplex virus-mediated gene transfer: implications for autologous vaccine production

Human Gene Therapy
C TungY Fong

Abstract

Production of autologous tumor vaccines would be facilitated by the development of a rapid and efficient method for the transfer of genes into freshly isolated cells. To evaluate the potential of replication defective herpes simplex viral (HSV) amplicon vectors as gene transfer vehicles for tumor vaccine generation, a vector that expresses the human interleukin-2 (IL-2) gene (HSV-IL2) and one that expresses Escherichia coli beta-galactosidase (HSVlac) were tested in hepatoma cells of both murine and human origin. Gene transfer into murine hepatoma cells (HEPA 1-6) was both rapid and highly efficient: greater than 50% of cells expressed beta-Gal when infected at a multiplicity of infection (m.o.i.) of 1 with an exposure period of 20 min. Moreover, gene transfer was as efficient in tumor cells after irradiation with 10,000 rads as in nonirradiated tumor cells. Irradiated HEPA 1-6 cells infected with HSV-IL2 for 20 min secreted IL-2 at a rate of 1,200 +/- 160 ng/10(6) cells per day. C57B1/6J mice immunized with irradiated, HSV-IL-2-transduced tumor cells produced in this way demonstrated specific tumor immunity by in vitro splenocyte tumoricidal activity and by in vivo protection against tumor challenge. Human hepatobiliary tumor ...Continue Reading

References

May 1, 1992·Journal of Virology·P A JohnsonT Friedmann
Aug 25, 1992·Nucleic Acids Research·W R JarnaginD M Bissell
May 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·J M WilsonR C Mulligan
Sep 1, 1995·Stroke; a Journal of Cerebral Circulation·M D LinnikH J Federoff
Aug 1, 1993·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·D A Leib, P D Olivo
Jul 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·P J BergoldH J Federoff

❮ Previous
Next ❯

Citations

Aug 21, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Adam VigilAdolfo García-Sastre
Apr 12, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Paula Y P LamKam M Hui
Jun 10, 1998·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·S BasakC D Morrow
Jun 21, 2001·Journal of the National Cancer Institute·M E WilcoxP A Forsyth
Feb 15, 1997·The Journal of Clinical Investigation·H M KarpoffY Fong
Oct 6, 2000·Molecular Therapy : the Journal of the American Society of Gene Therapy·M TodaS D Rabkin
Sep 8, 2001·Molecular Therapy : the Journal of the American Society of Gene Therapy·J F CarewY Fong
Apr 11, 2006·Cancer Gene Therapy·Y Shen, J Nemunaitis
Oct 19, 2005·Gene Therapy·Alberto L Epstein
Jul 31, 1999·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·D A KoobyY Fong
Nov 20, 2020·International Journal of Molecular Sciences·June Kyu HwangChae-Ok Yun
Mar 10, 2001·The Annals of Thoracic Surgery·R P Scott

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.